NTX-001 to Repair Peripheral Nerve Transection(s)

NCT05565846 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2025-05-22

No results posted yet for this study

Summary

The proposed use of NTX-001 for transections of upper extremity and facial peripheral nerves, acutely or planned.

Conditions

  • Peripheral Nerve Transections, Acute or Planned in Upper Extremity and Facial Nerves

Interventions

COMBINATION_PRODUCT

NTX-001

One-time use surgical product of three solutions and a device

Sponsors & Collaborators

  • Neuraptive Therapeutics Inc.

    lead INDUSTRY

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05565846 on ClinicalTrials.gov